Astrana Health (ASTH) Competitors

Astrana Health (NASDAQ:ASTH) and Sezzle (NASDAQ:SEZL) are both business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations.

Which has more volatility and risk, ASTH or SEZL?

Astrana Health has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500. Comparatively, Sezzle has a beta of 9.16, suggesting that its share price is 816% more volatile than the S&P 500.

Do institutionals & insiders believe in ASTH or SEZL?

52.8% of Astrana Health shares are owned by institutional investors. Comparatively, 2.0% of Sezzle shares are owned by institutional investors. 20.0% of Astrana Health shares are owned by insiders. Comparatively, 49.5% of Sezzle shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Does the media prefer ASTH or SEZL?

In the previous week, Sezzle had 1 more articles in the media than Astrana Health. MarketBeat recorded 9 mentions for Sezzle and 8 mentions for Astrana Health. Sezzle's average media sentiment score of 1.02 beat Astrana Health's score of 0.54 indicating that Sezzle is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Astrana Health	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Sezzle	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has preferable earnings and valuation, ASTH or SEZL?

Sezzle has lower revenue, but higher earnings than Astrana Health. Astrana Health is trading at a lower price-to-earnings ratio than Sezzle, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrana Health	$2.25B	0.58	$43.15M	$0.72	32.28
Sezzle	$329.06M	15.22	$78.52M	$2.96	50.82

Do analysts rate ASTH or SEZL?

Astrana Health currently has a consensus price target of $53.29, indicating a potential upside of 129.29%. Sezzle has a consensus price target of $108.28, indicating a potential downside of 28.02%. Given Astrana Health's higher possible upside, equities research analysts plainly believe Astrana Health is more favorable than Sezzle.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.67
Sezzle	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is ASTH or SEZL more profitable?

Sezzle has a net margin of 32.42% compared to Astrana Health's net margin of 1.56%. Sezzle's return on equity of 114.37% beat Astrana Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Astrana Health	1.56%	4.90%	2.68%
Sezzle	32.42%	114.37%	35.02%

Summary

Sezzle beats Astrana Health on 12 of the 16 factors compared between the two stocks.